Evidence map›Paper›PMID 26659096›Full record

ArticleInternational drug discovery

Diagnosing and Treating Nervous System Disorders by Targeting Novel Classes of Non-coding RNAs.

Irfan A Qureshi, Mark F Mehler

Abstract read
PubMed Full text at PMC
In one paragraph

Article in International drug discovery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Irfan A QureshiRosyln and Leslie Goldstein Laboratory for Stem Cell Biology and Regenerative Medicine, Albert Einstein College of Medicine ; Institute for Brain Disorders and Neural Regeneration, Albert Einstein College of Medicine ; Departments of Neurology, Albert Einstein College of Medicine ; Rose F. Kennedy Center for Research on Intellectual and Developmental Disabilities, Albert Einstein College of Medicine.
Mark F MehlerRosyln and Leslie Goldstein Laboratory for Stem Cell Biology and Regenerative Medicine, Albert Einstein College of Medicine ; Institute for Brain Disorders and Neural Regeneration, Albert Einstein College of Medicine ; Departments of Neurology, Albert Einstein College of Medicine ; Neuroscience, Albert Einstein College of Medicine ; Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine ; Rose F. Kennedy Center for Research on Intellectual and Developmental Disabilities, Albert Einstein College of Medicine.

Funding

Neurodegenerative Diseases: A New Class of Primary Developmental Disorders?R01NS071571 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MEHLER, MARK F · 2010 to 2013
$1.3M
NINDS NIH HHS R01 NS071571
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26659096
PMCPMC4675140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.